Article
Olanzapine induces SREBP-1-related adipogenesis in 3T3-L1 cells.
Pharmacological research - 1 Sept 2007
Yang Li-Hung, Chen Tzer-Ming, Yu Sung-Tsai, Chen Yen-Hui
Abstract excerpt
Olanzapine is a second-generation atypical antipsychotic drug (AAPD). Major side effects of olanzapine are weight gain and development of diabetes mellitus, which are risk factors of cardiovascular diseases. The possible causes of metabolic adverse effects are known as poor satiety and increased food intake due to blockade of receptors such as 5-HT(2C) in CNS. In this study, we examine the effect of olanzapine on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
